Charles Taersk
Member since: Oct '18
President and CEO at
Faircourt Asset Management

Latest Top Picks

This company was founded by pharmacists who is globally focused in generic drug manufacturing in 115 countries. They win 38% of new patients added to new medical cannabis users. They hire doctors to educate doctors about medical usages. Yield 0%. (Analysts’ price target is $16.93)
This trades at low valuations – 12 times earnings. A low cost producer in New Brunswick. Yield 0%. (Analysts’ price target is $9.09)
Although one of the top three cannabis producers in Canada it trades at a significantly lower valuation. Yield 0%. (Analysts’ price target is $25.56)